HOMOZYGOUS DELETIONS OF THE P15 (MTS2) AND P16 (CDKN2/MTS1) GENES IN ADULT T-CELL LEUKEMIA

被引:161
作者
HATTA, Y [1 ]
HIRAMA, T [1 ]
MILLER, CW [1 ]
YAMADA, Y [1 ]
TOMONAGA, M [1 ]
KOEFFLER, HP [1 ]
机构
[1] NAGASAKI UNIV,SCH MED,INST ATOM DIS,DEPT HEMATOL,NAGASAKI 852,JAPAN
关键词
D O I
10.1182/blood.V85.10.2699.bloodjournal85102699
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adult T-cell leukemia (ATL) is associated with prior infection with human T-cell leukemia virus type I (HTLV-I), Twenty to 40 years often elapse from viral infection to overt ATL, suggesting that other genetic events must occur to produce frank leukemia. The p15 (MTS2) and pie (CDKN2/MTS1) genes located on chromosome 9p have been implicated as candidate tumor-suppressor genes in several types of tumors. We examined for alterations of these genes in ATL using Southern blot and polymerase chain reaction-single-strand conformation polymorphism analyses. Both p15 and p16 genes were homozygously deleted in 4 of 23 acute/lymphomatous ATL (17%). An additional 3 (13%) and 4 (17%) acute/lymphomatous samples had hemizygous deletions in at least one exon of p15 and p16, respectively. One of 14 chronic ATL samples had a homozygously deleted p16 gene and another had a hemizygous deletion of p16, Neither homozygous nor hemizygous deletions of the p15 gene were found in chronic ATL, In total, 10 of 37 (27%) ATL samples had loss of the p15 and/or p16 genes. No point mutations of the p15 and pie genes were found. The ATL patient with a homozygously deleted pie in the chronic phase rapidly progressed to acute ATL and died within 6 months of the initial diagnosis. One instructive patient had no detectable deletion of the p15 and p16 genes during the chronic phase of ATL but had a homozygous deletions of both genes when she progressed to acute ATL, Our results suggest an association of p15/p16 deletions with development of acute ATL. (C) 1995 by The American Society of Hematology,
引用
收藏
页码:2699 / 2704
页数:6
相关论文
共 45 条
[1]  
BATES S, 1994, ONCOGENE, V9, P71
[2]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32
[3]  
CHENG JQ, 1994, CANCER RES, V54, P5547
[4]   GROWTH SUPPRESSION BY P18, A P16(INK4/MTS1)-RELATED AND P14(INK4B/MTS2)-RELATED CDK6 INHIBITOR, CORRELATES WITH WILD-TYPE PRB FUNCTION [J].
GUAN, KL ;
JENKINS, CW ;
LI, Y ;
NICHOLS, MA ;
WU, XY ;
OKEEFE, CL ;
MATERA, AG ;
XIONG, Y .
GENES & DEVELOPMENT, 1994, 8 (24) :2939-2952
[5]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[6]   SOMATIC MUTATIONS OF THE MTS (MULTIPLE TUMOR-SUPPRESSOR)-1 CDK41 (CYCLIN-DEPENDENT KINASE-4 INHIBITOR) GENE IN HUMAN PRIMARY NONSMALL CELL LUNG CARCINOMAS [J].
HAYASHI, N ;
SUGIMOTO, Y ;
TSUCHIYA, E ;
OGAWA, M ;
NAKAMURA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (03) :1426-1430
[7]   CANDIDATE TUMOR-SUPPRESSOR GENES MTS1 (P16(INK4A)) AND MTS2 (P15(INK4B)) DISPLAY FREQUENT HOMOZYGOUS DELETIONS IN PRIMARY-CELLS FROM T-CELL BUT NOT FROM B-CELL LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIAS [J].
HEBERT, J ;
CAYUELA, JM ;
BERKELEY, J ;
SIGAUX, F .
BLOOD, 1994, 84 (12) :4038-4044
[8]   FUNCTION OF A HUMAN CYCLIN GENE AS AN ONCOGENE [J].
HINDS, PW ;
DOWDY, SF ;
EATON, EN ;
ARNOLD, A ;
WEINBERG, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) :709-713
[9]   CYCLINS AND CANCER [J].
HUNTER, T ;
PINES, J .
CELL, 1991, 66 (06) :1071-1074
[10]   GERMLINE P16 MUTATIONS IN FAMILIAL MELANOMA [J].
HUSSUSSIAN, CJ ;
STRUEWING, JP ;
GOLDSTEIN, AM ;
HIGGINS, PAT ;
ALLY, DS ;
SHEAHAN, MD ;
CLARK, WH ;
TUCKER, MA ;
DRACOPOLI, NC .
NATURE GENETICS, 1994, 8 (01) :15-21